The new global chair of Baker McKenzie’s health care and life sciences group has had her hands full during the COVID-19 pandemic.

Early on in Latin America, where Vanina Caniza is based, clients in the pharmaceutical and medical device industry faced supply chain disruptions due to limits on production capacity and logistical hurdles as governments around the world restricted movement in an effort to contain the virus.